Personal identification

Full name

Patrícia Borges Alves

Citation names

• Alves, Patrícia

Author identifiers

Ciência ID

0310-2648-AA9F

ORCID iD

0000-0002-0650-2445

Email addresses

• patriciabalves05@gmail.com (Professional)

	Degree	Classification
2016/09 - 2019/05 Concluded	Oncobiologia (Mestrado integrado) Universidade de Lisboa Faculdade de Medicina, Portugal "“YB-1 expression in breast cancer: modulation of receptor status and therapeutic implications” (19/20)" (THESIS/DISSERTATION)	18/20
2012/09 - 2016/02 Concluded	Bioquímica (Licenciatura) Universidade do Algarve, Portugal ""Basal Activity of bidirectional Promoter shared by OPTN and CCDC3 and the role of NFkB in genes expression" (18/20)" (THESIS/DISSERTATION)	14

Science

	Category Host institution	Employer
2019/01 - Current	Researcher (Research)	Instituto de Medicina Molecular João Lobo Antunes, Portugal
	Instituto de Medicina Molecular João Lobo Antunes, Portugal

Others

	Category Host institution	Employer
2017/09 - 2019/05	Estudante mestrado - Oncobiologia	Instituto de Medicina Molecular João Lobo Antunes, Portugal
2015/09 - 2016/02	Aluna de licenciatura(Dissertação)	Universidade do Algarve Centro de Investigação em Biomedicina, Portugal

Other

	Designation	Funders
2019/01 - Current	Oncodynamics FPJ000900 Research Fellow	Ongoing
2019/01 - Current	RAdium-223 Dichloride Effect in the Metabolism of BOne Turnover Markers RAMBO-223 Research Fellow Instituto de Medicina Molecular João Lobo Antunes, Portugal	Ongoing

Publications

Conference poster	Alves, Patrícia. "Immune Cell Populations in Peripheral Blood of Metastatic Breast Cancer Patients Under CDK4/6 inhibitors". Paper presented in SABCS, 2020. Alves, Patrícia. "Phenotypic profiling of circulating tumour cells during metastatic disease progression.". Paper presented in Liquid Biopsy Symposium, Santiago Compostela,, 2020. Alves, Patrícia. "T cell profiling in metastatic breast cancer reveals a subtype independent immunosuppressive state". Paper presented in ASEICA_ASPIC Salamanca, 2019.
Journal article	Alves, Patrícia. "Expression of Receptor Activator of NFkB (RANK) drives stemness and resistance to therapy in ER+HER2- breast cancer". Oncotarget (2020): Accepted
Thesis / Dissertation	Alves, Patrícia. "YB-1 expression in breast cancer: modulation of receptor status and therapeutic implications". Master, Instituto de Medicina Molecular João Lobo Antunes, 2019. Alves, Patrícia. "“Basal Activity of bidirectional Promoter shared by OPTN and CCDC3 and the role of NFkB in genes expression”". Degree, Universidade do Algarve Centro de Investigação em Biomedicina, 2016.